\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesThe European Partnership for Personalised Medicine (EP PerMed) is organising a Networking Support Call with the aim to encourage networking in the field of personalised medicine (PM) and thereby stimulating the translation and implementation of research outcomes into clinical practice.
In the Networking Support Call 2025 (NSC2025), applicants from previously funded ERA PerMed and EP PerMed projects, researchers from (inter)national projects related to health research towards PM approaches, and translational stakeholders from countries participating in EP PerMed are invited to apply for funding for a networking event. To connect to researchers from previously funded ERA PerMed and EP PerMed projects, these projects are presented in the EP PerMed project database.
Applicants can apply for funding of up to €30,000 per networking event to organise a single transnational European/international event focused on translational aspects of personalised medicine. Applicants can choose between a face-to-face meeting or a hybrid format.
An application template must be completed in an electronic submission system in order to participate in this competitive call. An information day will take place on 1 July. The call deadline is 29 September 2025.
More information on the eligibility criteria and on how to apply, can be found on the EP PerMed website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The City of Hasselt took part in the ONELAB project (2022–2025) as an end user. The project was funded under Horizon Europe (HORIZON-CL3-2021-DRS-01-05) and focused on developing modular Rapid Response Mobile Laboratories (RRML). These laboratories are designed for rapid deployment in a variety of settings to support disease monitoring.
